ABOUT THIS PODCAST 🔗

Update frequency:
monthly
Average audio length:
24 minutes
Guest interviews
English
Australia
91 episodes
since Sept. 25, 2019
episodic

LATEST EPISODE 🔗

Singular Health Group (ASX: SHG) is taking its 3DICOM medical imaging platform into the US healthcare market, with a major Florida project and a growing pipeline of commercial opportunities. In this Health Kick podcast, CEO Denning Chong explains how the company aims to reduce duplicate scans, expa…

SEARCH PAST EPISODES

Search past episodes of The Health Kick Podcast with Tim Boreham.

PREVIOUS EPISODES

Alterity Therapeutics is entering a pivotal phase as it prepares for a global Phase 3 trial of ATH434, a potential first-in-class treatment for multiple system atrophy. In this episode, CEO David Stamler discusses promising Phase 2 results, the science behind targeting toxic brain iron, upcoming r…
As consumers increasingly seek alternatives to alcohol, ⁠The Calmer Co⁠ is working to broaden awareness and accessibility of kava-based products in Australia and overseas. CEO Zane Yoshida joins Tim Boreham to discuss the company's latest product launch, changing consumer preferences, growth opport…
In this episode Tim chats to of James Agnew, CFO of Aroa Biosurgery (ASX:ARX) Learn more about your ad choices. Visit megaphone.fm/adchoices
In this episode Tim chats to Gordon Edwards, CEO of Health Food Symmetry Learn more about your ad choices. Visit megaphone.fm/adchoices
In this episode Tim chats to  Zane Yoshida, CEO and Founder of The Calmer Co (ASX:CCO) Learn more about your ad choices. Visit megaphone.fm/adchoices
In this episode Tim chats to Dr. Kilian Kelly, CEO and Managing Director of Cynata Therapeutics (ASX:CYP) Learn more about your ad choices. Visit megaphone.fm/adchoices
In this episode Tim chats to Dr Michael Thurn, Managing Director of Neurizon Therapeutics (ASX:NUZ) Learn more about your ad choices. Visit megaphone.fm/adchoices
In this episode Tim chats to Liz Dallimore, Managing Director of Argenica Therapeutics (ASX:AGN) Learn more about your ad choices. Visit megaphone.fm/adchoices
In this episode, Tim chats to David Stamler, Managing Director of Alterity Therapeutics (ASX:ATH) Learn more about your ad choices. Visit megaphone.fm/adchoices
Disclaimer: The podcast and artwork embedded on this page are from Stockhead, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.